In 2022, the main achievements of the RAD Research Group were:
a) As part of a worldwide network, using digital monitoring (mHealth) in rhinitis and asthma, we showed that: i) mHealth can effectively monitor disease control and its daily impact, using new, reliable cut-off values for patient-reported outcomes [https://doi.org/10.1002/clt2.12208]; [https://doi.org/10.1016/j.jaip.2022.12.005]; [https://doi.org/10.1016/j.jaip.2022.08.015]; ii) mHealth can reliably allow analysis of evolution of disease symptoms [https://doi.org/10.1111/all.15574]; iii) novel disease phenotypes can be detected using cluster analysis of mHealth data [https://doi.org/10.1016/j.pulmoe.2022.10.005]; [https://doi.org/10.1111/all.15275]; iv) mhealth can reliably analyse drug usage and clinical efficacy [https://doi.org/10.1016/j.jaip.2022.07.020]; [https://doi.org/10.1111/all.15371] [https://doi.org/10.1002/clt2.12128].
b) As part of study of the exposome novel evidences were gathered: i) exposure to air pollution can significantly worsen asthma and COPD, and low pollution or allergen environments can improve disease control [https://doi.org/10.1016/j.pulmoe.2021.12.007][https://doi.org/10.1111/all.15242]; ii) exposure to helminths may worsen asthma in children [https://doi.org/10.1016/j.jaci.2021.12.777].
Prizes and Awards
- SPAIC-ASTRAZENECA 2022 Prize, awarded to the project entitled"PAAI-Interactive and Online Self-Learning programme for people with asthma: protocol for co-creation and impact assessment", in October 2022. This is an ongoing project, which resulted from a partnership with the ConectAR initiative, of CINTESIS, Faculty of Medicine of the University of Porto.